COVERMYMEDS
LIVE

Serial Number

90818802

Owner

CoverMyMeds LLC

Attorney

Auma N. Reggy

Filing Date

Jul 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COVERMYMEDS Trademark

Serial Number: 90818802 • Registration: 7634132

COVERMYMEDS is a trademark filed by CoverMyMeds LLC on July 8, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

CoverMyMeds LLC (12 trademarks)

130 East Chestnut Street
Columbus, OH 43215

Entity Type: 16

Trademark Details

Filing Date

July 8, 2021

Registration Date

December 31, 2024

Published for Opposition

October 17, 2023

Goods & Services

Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments, and referrals that allow direct transaction and payment communications between healthcare providers, pharmacies, and payers

Financial administration of pharmaceutical manufacturer program that redeploys rebate funds directly to underinsured or uninsured consumers at the pharmacy counter; providing a patient financial assistance and financial support program for patients and their healthcare providers for the purpose of facilitating good health, namely, providing financial information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance

Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication

Providing medical advice and information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance; medication counseling, namely providing information about taking medication, medication side-effects, allergic sensitivity to medications, drug interactions, medication tolerance, and alternate medication brands and generics

Providing temporary use of a web-based software application for use in providing support for pharmacies and health systems that integrates with pharmacy management systems to facilitate dispensing of pharmaceuticals via remote prescription verification, audit trails with images of dispensed drug, alerts to avoid duplicate patient therapy, allergies, and drug interactions; Software as a service (SAAS) services featuring software for facilitating the prescription of, and access to covered specialty medications and medical treatments by enabling intra provider-insurer-pharmacy communications for purposes of investigating and verifying patient-specific benefits coverage, for processing prior medical authorizations, for locating and facilitating patient access to financial assistance, for scheduling laboratory tests and first dose observations, for transmitting prescriptions to a patient's preferred pharmacy, and for supporting pharmaceutical companies in risk evaluation and mitigation strategy programs, and, as related to the above, specifically excluding software permitting health care providers and patients to communicate via a customized private website to collect, analyze, manage, share, report or compare patient data, rehabilitation tracking and patient progress; Software as a service featuring software for integration of medical software with drug interaction references and recommendations from medical databases; Software as a service (SAAS) namely, hosting an online software platform for use by others that provides online price comparisons, cost analysis, coupons, and price quotations of pharmaceuticals and over the counter medications for consumers, providers, administrators, and other participants in the healthcare industry; Software as a service (SAAS) services featuring software for use by medical care providers, pharmacists, and benefit providers for utilizing, aggregating, analyzing, displaying, and updating medical health record data analytics, for use in prior authorization support, prescription benefit support, prescription decision support, and medical care support to improve clinical outcomes; Software as a service (SAAS) services featuring software for the purpose of integrating medical information in the fields of pharmaceuticals, drug interactions, and treatment guidelines for the purpose of reducing the time and effort required from all stakeholders to start specialty therapy with the goal of improving patient outcomes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 11, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 11, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 11, 2024 SUPC
USE AMENDMENT FILED
Jun 12, 2024 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 12, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 12, 2024 EEXT
TEAS STATEMENT OF USE RECEIVED
Jun 12, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 8, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 8, 2023 GNFN
FINAL REFUSAL E-MAILED
Jun 8, 2023 GNFR
FINAL REFUSAL WRITTEN
Jun 8, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2021 NWOS
NEW APPLICATION ENTERED
Jul 12, 2021 NWAP